Market Place
Sourcing Support
Anaveon to Present Data on ANV700 & ANV600 at SITC 2024
30 Oct 2024 //
GLOBENEWSWIRE
Anaveon appoints Dieter Weinand as Chair of its Board of Directors
30 Jul 2024 //
GLOBENEWSWIRE
Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
29 May 2024 //
GLOBENEWSWIRE
Anaveon announces presentation of a novel development compound at the 2023
23 Mar 2023 //
GLOBENEWSWIRE
Anaveon announces first patient dosed with ANV419 in a Ph I/II Study of ANV419
16 Mar 2023 //
GLOBENEWSWIRE
Anaveon doses first patient in a Phase I/II Study of ANV419 as monotherapy
02 Feb 2023 //
GLOBENEWSWIRE
Anaveon presents updated data from the PI/II study of ANV419 during the ESMO
09 Sep 2022 //
GLOBENEWSWIRE
Anaveon presents compelling data from the Phase I/II study of ANV419
08 Apr 2022 //
GLOBENEWSWIRE
Pfizer, Novartis back $119M Anaveon series B for phase 2 trials
17 Dec 2021 //
FIERCEBIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.